Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

2020

Bone Therapeutics: Information on the total number of voting rights and shares (March 2020)

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares (March 2020)

Bone Therapeutics appoints Stefanos Theoharis as Chief Business Officer

  • Read more about Bone Therapeutics appoints Stefanos Theoharis as Chief Business Officer

Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates

  • Read more about Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates

Bone Therapeutics announces 2019 full year results

  • Read more about Bone Therapeutics announces 2019 full year results

Bone Therapeutics: Information on the total number of voting rights and shares (February 2020)

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares (February 2020)

Bone Therapeutics to present preclinical data on the osteogenic properties of ALLOB in bone repair at the Annual Meeting of the ORS

  • Read more about Bone Therapeutics to present preclinical data on the osteogenic properties of ALLOB in bone repair at the Annual Meeting of the ORS

Bone Therapeutics: Information on the total number of voting rights and shares (January 2020)

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares (January 2020)

Bone Therapeutics announces 2020 business outlook and reports year-end 2019 cash position

  • Read more about Bone Therapeutics announces 2020 business outlook and reports year-end 2019 cash position

Bone Therapeutics announces attendance at the 38th Annual J.P. Morgan Healthcare Conference

  • Read more about Bone Therapeutics announces attendance at the 38th Annual J.P. Morgan Healthcare Conference

Interview with Miguel Forte – CEO, Bone Therapeutics

  • Read more about Interview with Miguel Forte – CEO, Bone Therapeutics

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to 2020
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions